Issam Zineh - Alachua FL, Hooman Allayee - Los Angeles CA,
A61K 31/40 A61P 29/00 C12Q 1/68
The invention concerns polymorphisms in the CXCL5 gene and the concentration of epithelial neutrophil activating peptide (ENA-78) in patients. The invention also pertains to methods and systems for detecting such polymorphisms. The invention further relates to the use of such methods and systems in the diagnosis, prognosis, and treatment selection for inflammatory disorders associated with elevated ENA-78 concentrations.